Psychedelics could significantly alleviate the anguish, debilitating depression and death-anxiety often experienced by the terminally ill but its implications could be much more profound, clinicians say.
In an Australian-first, a near three-year clinical trial examined the use of psilocybin - a naturally occurring compound found in some species of mushrooms - in combination with psychotherapy for dozens of people living with crippling, life-threatening illness.
